VENUS REMEDIES LTD. SHARE PRICE [LIVE]
BSE: INE411B01019 NSE: VENUSREM SECTOR: Pharma
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Mar 21 | Dec 20 |
|---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in VENUS REMEDIES LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
VENUSREM News
- SATIN CREDITCARE NETWORK LTD
- SOURCE INDUSTRIES (INDIA) LTD.
- TRANSPEK INDUSTRY LTD.
- RPG LIFE SCIENCES LTD.
- CAPITAL INDIA FINANCE LTD
- FRESHTROP FRUITS LTD.
- SHREE KARTHIK PAPERS LTD.
- VINTRON INFORMATICS LTD.
- CEETA INDUSTRIES LTD.
- NAAPBOOKS LIMITED
- BRIGHT SOLAR LIMITED
- ENTERTAINMENT NETWORK (INDIA) LTD.
- APOLLO TYRES LTD
- ASIT C.MEHTA FINANCIAL SERVICES LTD.
- SIDH AUTOMOBILES LTD
- HINDUSTHAN UDYOG LTD.
- MINI DIAMONDS (INDIA) LIMITED
- PANACHE INNOVATIONS LTD
- SPACEAGE PRODUCTS LTD
- SARUP INDUSTRIES LTD.
Frequently Asked Questions
What is the Share price of VENUS REMEDIES LTD. (VENUSREM)?
Can I buy VENUS REMEDIES LTD. (VENUSREM) shares?
How do I buy VENUS REMEDIES LTD. (VENUSREM) from Angel One?
- Direct investment: You can buy VENUS REMEDIES LTD. (VENUSREM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to VENUS REMEDIES LTD. (VENUSREM) shares.
In which sector do VENUS REMEDIES LTD. (VENUSREM) belong?
About VENUSREM
Today's live share price for VENUS REMEDIES LTD. is NSE: ₹ 215.60, BSE: ₹ 215.90 with a current market capitalization of .
Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc. In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.
Read more
